News

The Federal District Court of the District of Delaware has dismissed the Danish company’s claims against UK biotech Acambis, cancelling an upcoming trial over the allegations. Bavarian Nordic

Under the terms of the agreement, which will run for 18 months, Proteros will receive research funding fees and success payments for the generation and analyses of protein-ligand-structures

Southwest Oncology Group (SWOG) added that study participants would be given the choice of switching to Revlimid with dexamethasone. According to SWOG, the 198 patients enrolled in the

Pravachol, a cholesterol-lowering drug, has annual sales of over $861 million, according to Glenmark. The generics company said that it is manufacturing the formulation in its facility in

The combination pediatric vaccine, currently in phase III studies, shows potential to protect children in the first year of life against Neisseria meningitidis serogroups C (MenC) and Y

Vinita Gupta, president and managing director of Lupin, said: “We are delighted to receive final FDA approval for simvastatin tablets. The addition of generic Zocor complements Lupin’s commitment

Acambis developed ACAM2000 under contracts with the US Centers for Disease Control and Prevention in response to the US government’s need for a stockpile of smallpox vaccine to

New York-based Siga said that it expects the results from the study to be used as one of the two animal models required for the FDA’s “animal efficacy

The trial will test the hypothesis that patients with COPD are more likely to have a good clinical response to inhaled steroids if they have a positive Aridol